Literature DB >> 21865270

Measuring continuous baseline covariate imbalances in clinical trial data.

Jody D Ciolino1, Reneé H Martin2, Wenle Zhao2, Michael D Hill3, Edward C Jauch4, Yuko Y Palesch2.   

Abstract

This paper presents and compares several methods of measuring continuous baseline covariate imbalance in clinical trial data. Simulations illustrate that though the t-test is an inappropriate method of assessing continuous baseline covariate imbalance, the test statistic itself is a robust measure in capturing imbalance in continuous covariate distributions. Guidelines to assess effects of imbalance on bias, type I error rate and power for hypothesis test for treatment effect on continuous outcomes are presented, and the benefit of covariate-adjusted analysis (ANCOVA) is also illustrated.
© The Author(s) 2011 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  baseline; clinical trial; covariate; imbalance

Mesh:

Substances:

Year:  2011        PMID: 21865270      PMCID: PMC4280338          DOI: 10.1177/0962280211416038

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  21 in total

1.  Understanding controlled trials: baseline imbalance in randomised controlled trials.

Authors:  C Roberts; D J Torgerson
Journal:  BMJ       Date:  1999-07-17

2.  Optimal multivariate matching before randomization.

Authors:  Robert Greevy; Bo Lu; Jeffrey H Silber; Paul Rosenbaum
Journal:  Biostatistics       Date:  2004-04       Impact factor: 5.899

3.  Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization.

Authors:  Jody Ciolino; Wenle Zhao; Renee' Martin; Yuko Palesch
Journal:  Contemp Clin Trials       Date:  2010-11-13       Impact factor: 2.226

4.  Rank-Minimization for balanced assignment of subjects in clinical trials.

Authors:  Bjarne Stigsby; Donald R Taves
Journal:  Contemp Clin Trials       Date:  2010-01-06       Impact factor: 2.226

Review 5.  Should we adjust for covariates in nonlinear regression analyses of randomized trials?

Authors:  W W Hauck; S Anderson; S M Marcus
Journal:  Control Clin Trials       Date:  1998-06

6.  A treatment allocation procedure for sequential clinical trials.

Authors:  C B Begg; B Iglewicz
Journal:  Biometrics       Date:  1980-03       Impact factor: 2.571

7.  How to select covariates to include in the analysis of a clinical trial.

Authors:  G M Raab; S Day; J Sales
Journal:  Control Clin Trials       Date:  2000-08

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.

Authors:  Stuart J Pocock; Susan E Assmann; Laura E Enos; Linda E Kasten
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

10.  Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.

Authors:  Timothy John Ingall; William Michael O'Fallon; Kjell Asplund; Lewis Robert Goldfrank; Vicki S Hertzberg; Thomas Arthur Louis; Teresa J Hengy Christianson
Journal:  Stroke       Date:  2004-09-02       Impact factor: 7.914

View more
  14 in total

1.  Continuous covariate imbalance and conditional power for clinical trial interim analyses.

Authors:  Jody D Ciolino; Renee' H Martin; Wenle Zhao; Edward C Jauch; Michael D Hill; Yuko Y Palesch
Journal:  Contemp Clin Trials       Date:  2014-03-07       Impact factor: 2.226

2.  Underreporting of Gender and Race/Ethnicity Differences in NIH-Funded Dementia Caregiver Support Interventions.

Authors:  Andrea Gilmore-Bykovskyi; Rachel Johnson; Lily Walljasper; Laura Block; Nicole Werner
Journal:  Am J Alzheimers Dis Other Demen       Date:  2017-12-27       Impact factor: 2.035

3.  A group sequential test for treatment effect based on the Fine-Gray model.

Authors:  Michael J Martens; Brent R Logan
Journal:  Biometrics       Date:  2018-03-13       Impact factor: 2.571

4.  Group sequential tests for treatment effect on survival and cumulative incidence at a fixed time point.

Authors:  Michael J Martens; Brent R Logan
Journal:  Lifetime Data Anal       Date:  2019-11-15       Impact factor: 1.588

5.  Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's Disease.

Authors:  D James Surmeier; Jack T Nguyen; Nicola Lancki; Charles S Venuto; David Oakes; Tanya Simuni; Richard K Wyse
Journal:  Mov Disord       Date:  2021-11-12       Impact factor: 10.338

6.  Impact of minimal sufficient balance, minimization, and stratified permuted blocks on bias and power in the estimation of treatment effect in sequential clinical trials with a binary endpoint.

Authors:  Steven D Lauzon; Wenle Zhao; Paul J Nietert; Jody D Ciolino; Michael D Hill; Viswanathan Ramakrishnan
Journal:  Stat Methods Med Res       Date:  2021-11-29       Impact factor: 2.494

7.  Covariate imbalance and adjustment for logistic regression analysis of clinical trial data.

Authors:  Jody D Ciolino; Renée H Martin; Wenle Zhao; Edward C Jauch; Michael D Hill; Yuko Y Palesch
Journal:  J Biopharm Stat       Date:  2013       Impact factor: 1.051

8.  Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study.

Authors:  Bolaji E Egbewale; Martyn Lewis; Julius Sim
Journal:  BMC Med Res Methodol       Date:  2014-04-09       Impact factor: 4.615

9.  Testing for baseline differences in randomized controlled trials: an unhealthy research behavior that is hard to eradicate.

Authors:  Michiel R de Boer; Wilma E Waterlander; Lothar D J Kuijper; Ingrid H M Steenhuis; Jos W R Twisk
Journal:  Int J Behav Nutr Phys Act       Date:  2015-01-24       Impact factor: 6.457

Review 10.  Value-Generating Exploratory Trials in Neurodegenerative Dementias.

Authors:  Lauren G Friedman; Nicholas McKeehan; Yuko Hara; Jeffrey L Cummings; Dawn C Matthews; Jian Zhu; Richard C Mohs; Deli Wang; Suzanne B Hendrix; Melanie Quintana; Lon S Schneider; Michael Grundman; Samuel P Dickson; Howard H Feldman; Judith Jaeger; Elizabeth C Finger; J Michael Ryan; Debra Niehoff; Susan L-J Dickinson; Jessica T Markowitz; Meriel Owen; Alessio Travaglia; Howard M Fillit
Journal:  Neurology       Date:  2021-03-05       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.